Logo Lanfrica
  • Accueil
  • Atlas
  • Analyses
  • Documentation
  • Sign in

© 2026 Lanfrica. Tous droits réservés. Tous les droits d'auteur des ressources affichées sur le site Web Lanfrica appartiennent aux détenteurs de droits d'auteur d'origine, sauf indication contraire explicite.

Clinically immune hosts as a refuge for drug-sensitive malaria parasites-0

Domaine:

healthcare

Type de record:

paper
Créateur:
EilDavMacRam
Hôte:avatar
T the rate () and resistant infections at the rate , where is the happenings rate (see text) and is the rate at which new infections result in clinically manifested symptoms that are treated and resolved prior to the formation of gametocytes. Infected individuals naturally clear resistant infections at rate , and they clear wild-type infections at the rate +, where is the rate of drug treatment. Infected individuals acquire semi-immunity at rate and lose immunity at rate if they are no longer infected. Individuals die from all states at a background rate of μ and are born at rate as nonimmune susceptibles (process not shown).

Copyright information:

Taken from "Clinically immune hosts as a refuge for drug-sensitive malaria parasites"

malariajournal.com

Malaria Journal 2008;7():67-67.

Published online 25 Apr 2008

PMCID:PMC2409364.

Visit

figshare.com

Tags

Veterinary parasitologyMedical parasitologyclinicallyimmunehostsrefugedrugsensitivemalariaParasitology

Licenses

CC BY 4.0

Similaires

Prevalence of Plasmodium Parasites Among Clinically Malaria Suspected Febrile Patients in Katsina StateA rapid and robust selection procedure for generating drug-selectable marker-free recombinant malaria parasitesWorld Antimalarial Resistance Network (WARN) III: Molecular markers for drug resistant malaria-0Investigating natural products as new drug leads for malariaDroplet microfluidics platform for highly sensitive and quantitative detection of malaria-causing plasmodium parasites based on enzyme activity measurement.CLINICALLY SIGNIFICANT DRUG-DRUG INTERACTION IN A LARGE ANTIRETROVIRAL TREATMENT CENTRE IN LAGOS, NIGERIA

Prevalence of Plasmodium Parasites Among Clinically Malaria Suspected Febrile Patients in Katsina State

Malaria is the leading parasitic disease in terms of human morbidity and mortality, imposing substan

A rapid and robust selection procedure for generating drug-selectable marker-free recombinant malaria parasites

International audience Experimental genetics have been widely used to explore the bio

World Antimalarial Resistance Network (WARN) III: Molecular markers for drug resistant malaria-0

Copyright information:

Taken from "World Antimalarial Resistance Network (WARN) III:

Investigating natural products as new drug leads for malaria

Despite being preventable and treatable, malaria continues to be a significant threat to global heal

Droplet microfluidics platform for highly sensitive and quantitative detection of malaria-causing plasmodium parasites based on enzyme activity measurement.

International audience We present an attractive new system for the specific and sensi

CLINICALLY SIGNIFICANT DRUG-DRUG INTERACTION IN A LARGE ANTIRETROVIRAL TREATMENT CENTRE IN LAGOS, NIGERIA

Background An important cause of treatment failure to antiretroviral therapy (AR